Table 2: GSM symptoms evaluated using VAS at T2 and T4.
| VAS | Baseline (T0) | 4 week FUP (T2) | 8 week FUP (T4) |
| 0 | 0 | 0 | 0 |
| 1 | 0 | 15/80 (19%) | 56/80 (70%) |
| 2-3 | 4/80 (5%) | 5/80 (6%) | 12/80 (15%) |
| 4-5 | 8/80 (10%) | 12/80 (15%) | 8/80 (10%) |
| 6-7 | 11/80 (14%) | 25/80 (31%) | 0 |
| 8-9 | 37/80 (46%) | 17/80 (21%) | 4/80 (5%) |
| 10 | 20/80 (25%) | 6/80 (8%) | 0 |